Cite
HARVARD Citation
Nili Gal Yam, E. et al. (n.d.). 22PESR1 mutations are similarly prevalent in newly metastatic and loco-regional recurrence of endocrine-treated breast cancer patients and carry worse prognosis. Annals of oncology. p. . [Online].